End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
55.2 TWD | -0.36% | +0.91% | -20.35% |
03-20 | CHO Pharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | CHO Pharma, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Sales 2022 | 60K 1.84K 147K | Sales 2023 | - | Capitalization | 14.83B 455M 36.41B |
---|---|---|---|---|---|
Net income 2022 | -338M -10.37M -830M | Net income 2023 | -306M -9.39M -751M | EV / Sales 2022 | 402,853 x |
Net cash position 2022 | 1.03B 31.7M 2.54B | Net cash position 2023 | 2.6B 79.89M 6.39B | EV / Sales 2023 | - |
P/E ratio 2022 |
-74.5
x | P/E ratio 2023 |
-43.3
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 100% |
1 day | -0.36% | ||
1 week | +0.91% | ||
Current month | -7.38% | ||
1 month | -5.80% | ||
3 months | -14.55% | ||
6 months | -31.00% | ||
Current year | -20.35% |
Managers | Title | Age | Since |
---|---|---|---|
Tsung I Wu
CEO | Chief Executive Officer | - | - |
Chao-Long Chen
CHM | Chairman | - | 26/12/17 |
Yi Pei Chou
DFI | Director of Finance/CFO | - | 27/03/16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ming Hsing Tsai
BRD | Director/Board Member | 66 | 26/05/13 |
Hsuan Ta Liu
BRD | Director/Board Member | - | 05/06/19 |
Chao-Long Chen
CHM | Chairman | - | 26/12/17 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 117 M€ | +1.11% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 55.2 | -0.36% | 155,192 |
25/04/24 | 55.4 | -1.95% | 239,770 |
24/04/24 | 56.5 | +1.99% | 387,702 |
23/04/24 | 55.4 | -0.18% | 255,419 |
22/04/24 | 55.5 | +1.46% | 582,888 |
End-of-day quote Taipei Exchange, April 25, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-20.35% | 362M | |
-4.66% | 86.13B | |
+1.32% | 39.82B | |
-19.27% | 30.42B | |
+57.86% | 25.23B | |
-16.09% | 15.36B | |
-9.14% | 11.95B | |
-17.69% | 11.6B | |
-43.00% | 11.51B | |
+5.24% | 8.71B |
- Stock Market
- Equities
- 6586 Stock